Multidrug resistance in leukemia.
作者信息
Rischin D, Ling V
机构信息
Ontario Cancer Institute, Toronto, Canada.
出版信息
Cancer Treat Res. 1993;64:269-93. doi: 10.1007/978-1-4615-3086-2_13.
PMID:8095795
Abstract
摘要
相似文献
1
Multidrug resistance in leukemia.
Cancer Treat Res. 1993;64:269-93. doi: 10.1007/978-1-4615-3086-2_13.
2
Multidrug resistance: molecular biology and clinical relevance.
J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.
3
Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910.
4
Multidrug resistance: a novel class of membrane-associated transport proteins is identified.多重耐药性：一类新的膜相关转运蛋白被鉴定出来。
Cancer Invest. 1991;9(5):563-9. doi: 10.3109/07357909109018954.
5
Multidrug resistance due to P-glycoprotein.
Hosp Pract (Off Ed). 1990 Apr 15;25(4):67-72, 74, 77. doi: 10.1080/21548331.1990.11703935.
6
The role of P-glycoprotein in drug-resistant hematologic malignancies.
Cancer Treat Res. 1991;57:187-208. doi: 10.1007/978-1-4615-3872-1_9.
7
Multidrug resistance: clinical relevance in haematological malignancies.
Blood Rev. 1991 Mar;5(1):38-41. doi: 10.1016/0268-960x(91)90006-x.
8
Drug resistance and cancer.
Adv Exp Med Biol. 1993;330:287-305. doi: 10.1007/978-1-4615-2926-2_20.
9
Multidrug resistance in human cancer.人类癌症中的多药耐药性。
Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.
10
Laboratory aspects of multidrug resistance.
Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3.
引用本文的文献
1
Pharmacologic circumvention of multidrug resistance.多药耐药性的药理学规避
Cytotechnology. 1993;12(1-3):171-212. doi: 10.1007/BF00744664.
Zotero 插件